VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VKTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VKTXViking Therapeutics, Inc.
$38.71$4.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVKTXPrice History

VKTX logoViking Therapeutics, Inc. (VKTX) Stock Price History

Historical prices from 2015 to 2026

$38.71+1.27  (+3.39%)close Jul 6
Returns
1M
+32.4%
3M
+14.1%
YTD
+9.3%
1Y
+40.7%
3Y
+34.3%
5Y
+44.4%
ATH$99.41Feb 2024-61.1%
ATL$0.88Aug 2017pre-split
Avg Vol (50D)2.3M/ day
52-Week Range$22.96 — $43.15
LowCurrent: $38.71High

Loading 10-year price history...

VKTX Historical Performance

1 YearTotal Return
+40.7%
Price: +40.7%
3 YearsTotal Return
+142.1%
CAGR: +34.3%
Price: +142.1%
5 YearsTotal Return
+527.4%
CAGR: +44.4%
Price: +527.4%
YTD
+9.3%

VKTX Annual Returns

Year-by-year price performance · 2015–2026

Best+241.2%2017
Worst-64.3%2016
Up years5/12
2015-57.4%
2016-64.3%
2017+241.2%
2018+70.8%
2019-3.6%
2020-29.2%
2021-20.7%
2022+92.6%
2023+118.4%
2024+120.1%
2025-14.4%
2026-4.5%
2015 annual price return
-57.4%
2016 annual price return
-64.3%
2017 annual price return
+241.2%
2018 annual price return
+70.8%
2019 annual price return
-3.6%
2020 annual price return
-29.2%
2021 annual price return
-20.7%
2022 annual price return
+92.6%
2023 annual price return
+118.4%
2024 annual price return
+120.1%
2025 annual price return
-14.4%
2026 annual price return
-4.5%
LessMore
Alpha vs S&P 500
1Y+19.7%
3Y+0.2%
5Y+30.1%

Price returns only.

Download Historical Data

2,814 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

VKTX Stock Price Trajectory (2015–2026)

As of July 7, 2026, Viking Therapeutics, Inc. (VKTX) trades at $38.71, representing a +40.7% return over the past year. The stock has delivered a +527.4% total return over five years (+44.4% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $99.41 on February 28, 2024. From this peak, VKTX has corrected -61.1%, currently trading 17% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers TERN (+1223.8% 1Y), PEPG (+70.3% 1Y), and KYMR (+161.9% 1Y), VKTX has underperformed the peer group average. Compare VKTX vs TERN →

VKTX Historical Price Data · from 2015

Rows 1–50 of 2,814
Date Open High Low Close Volume Change %
2026-07-0637.2538.8737.1038.712.12M+3.39%
2026-07-0237.9038.8736.6937.442.47M-0.11%
2026-07-0138.9539.6636.9937.483.09M-3.92%
2026-06-3039.5041.4038.9539.013.05M-1.34%
2026-06-2938.0439.6437.4139.542.84M+3.94%
2026-06-2636.3538.4836.1438.040+2.84%
2026-06-2537.9939.4536.8736.994.26M-2.32%
2026-06-2435.6538.0835.0337.875.44M+8.79%
2026-06-2331.6735.9031.6734.816.16M+7.54%
2026-06-2230.5232.9030.5232.373.25M+6.55%
2026-06-1830.6931.5530.1630.382.63M+0.30%
2026-06-1730.0131.2729.6030.291.85M+2.16%
2026-06-1629.5030.3129.0029.651.32M+0.07%
2026-06-1529.1429.9329.0429.631.15M+3.06%
2026-06-1228.5029.2828.5028.751.15M+0.49%
2026-06-1127.6028.9027.1628.612.32M+3.10%
2026-06-1028.6929.0927.6127.752.69M-5.06%
2026-06-0929.7630.1028.3029.232.21M-0.03%
2026-06-0828.7529.6028.3929.241.88M+2.78%
2026-06-0529.5029.8028.0428.452.72M-4.47%
2026-06-0429.5530.1829.3829.781.62M+1.53%
2026-06-0329.1329.8029.0629.331.45M+0.14%
2026-06-0231.0231.0529.1729.292.74M-6.33%
2026-06-0132.5132.5131.2731.271.47M-4.49%
2026-05-2932.2233.1631.8232.741.69M+1.71%
2026-05-2831.6932.4431.4332.191.44M+1.67%
2026-05-2731.3032.2530.7531.661.72M+2.79%
2026-05-2630.9231.0030.0430.802.41M-0.29%
2026-05-2230.5830.9230.2930.891.20M+0.78%
2026-05-2129.1830.7828.8030.651.98M+4.11%
2026-05-2028.7229.6828.6129.441.64M+3.66%
2026-05-1928.8428.9428.1628.401.76M-1.01%
2026-05-1830.2730.4328.4228.693.26M-5.22%
2026-05-1531.4731.6830.2130.271.74M-4.54%
2026-05-1431.7831.9530.8231.711.43M-0.02%
2026-05-1331.3232.0331.0831.711.71M+1.26%
2026-05-1231.7231.7330.8231.321.33M-1.26%
2026-05-1131.3632.6731.0031.721.94M+1.24%
2026-05-0831.6831.8931.1431.331.44M-0.79%
2026-05-0732.1832.4330.8831.581.92M-2.17%
2026-05-0631.4832.3931.3232.282.26M+3.10%
2026-05-0532.0032.3330.4831.311.96M-1.42%
2026-05-0430.2532.4229.6531.761.60M+5.87%
2026-05-0131.3032.0029.7530.002.84M-3.78%
2026-04-3030.4831.6228.8231.186.08M-0.48%
2026-04-2932.2832.3831.1531.332.85M-3.27%
2026-04-2833.2033.8632.3632.391.82M-1.80%
2026-04-2732.8033.5932.6032.981.52M+0.72%
2026-04-2433.0133.1931.8232.751.91M-0.15%
2026-04-2334.5234.6632.3632.802.49M-4.23%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

VKTX — Frequently Asked Questions

Quick answers to the most common questions about buying VKTX stock.

How has VKTX stock performed recently?

VKTX returned +40.7% over the past year, beating its 5-year annualized CAGR of +44.4%. The stock trades above its 200-day moving average, confirming the uptrend.

What is VKTX's all-time high price?

Viking Therapeutics, Inc. reached $99.41 on 2024-02-28. The 52-week high is $43.15. Current 1-year return of +40.7% places the stock closer to historical peaks.

Where can I download VKTX historical price data?

This page provides VKTX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2015-2026, downloadable in CSV format.

470 data points · sampled from 2,814